BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2364870)

  • 1. [Short-term results of intratumor BCG injection for rectal carcinoma].
    Zhu HM
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):40-2. PubMed ID: 2364870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
    Millar JW; Hunter AM; Wightman AJ; Horne NW
    Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.
    Falk RE; MacGregor AB; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1976 Mar; 142(3):363-8. PubMed ID: 1251316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
    Tímár J; Ladányi A; Forster-Horváth C; Lukits J; Döme B; Remenár E; Godény M; Kásler M; Bencsik B; Répássy G; Szabó G; Velich N; Suba Z; Elo J; Balatoni Z; Pócza K; Zemplén B; Chretien P; Talor E
    J Clin Oncol; 2005 May; 23(15):3421-32. PubMed ID: 15908653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of chemoimmune prophylaxis of superficial bladder carcinoma (author's transl)].
    Adolphs HD; Helpap B
    Urologe A; 1982 Jan; 21(1):29-33. PubMed ID: 7200654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of bladder cancer with intralesional injection with BCG.
    Calsini P; Scapicchi G; Gazzarini O; Melone F; Aulisi A; Pellegrini G; Fabris N; Provinciali M
    J Exp Pathol; 1987; 3(4):579-86. PubMed ID: 3454805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemo-immunoprevention in superficial bladder cancer].
    Adolphs HD; Bastian HP
    Urologe A; 1986 Jan; 25(1):51-4. PubMed ID: 3962045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic effects of zhuling and BCG on postoperative recurrence of bladder cancer].
    Yang DA; Li SQ; Li XT
    Zhonghua Wai Ke Za Zhi; 1994 Jul; 32(7):433-4. PubMed ID: 7842985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exfoliation as a mode of cancer elimination in rectal carcinoma.
    Okuyama S; Mishina H; Hariu T; Yamamoto K; Matsushiro T; Yamagata R; Taima T
    Tohoku J Exp Med; 1984 Aug; 143(4):503-4. PubMed ID: 6495328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H; Shirahase T; Kihara Y; Arai Y
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of a clinical trial in 12 patients with head and neck cancer treated intratumorally and peritumorally with multikine.
    Feinmesser R; Hardy B; Sadov R; Shwartz A; Chretien P; Feinmesser M
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):874-81. PubMed ID: 12925348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-pathological studies on three preoperative combined treatments for rectal cancer].
    Yoshioka Y; Ichikawa D; Iizuka R; Hagiwara A; Sawai K; Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1551-4. PubMed ID: 7574757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
    de Reijke TM; Kurth KH; Sylvester RJ; Hall RR; Brausi M; van de Beek K; Landsoght KE; Carpentier P;
    J Urol; 2005 Feb; 173(2):405-9. PubMed ID: 15643181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.